TITLE

Valeant Buying Obagi for $344 Million

PUB. DATE
March 2013
SOURCE
MondayMorning;3/25/2013, Vol. 21 Issue 11, p1
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports that Valeant Pharmaceuticals Inc. is planning to purchase a pharma company Obagi Medical Products Inc. for 344 million U.S. dollar. It mentions that Valeant has signed an agreement to buy all outstanding shares of Obagi by paying 19.75 U.S. dollars for each share. It also informs that Valeant deals in designing the products for dermatology, neurology and branded generics.
ACCESSION #
86435128

 

Related Articles

  • 04/08 (5) Valeant Pharma Boosts Offer for Obagi to $418 Million.  // MondayMorning;4/8/2013, Vol. 21 Issue 13, p5 

    The article reports that dermatology products maker Obagi Medical Products Inc. has revealed that Canadian drugmaker Valeant Pharmaceuticals International Inc. has increased its bid to buy it. Obagi has made a deal with Valeant under which Valeant will pay 24 dollars per share. Obagi was earlier...

  • Merz Pharma Tops Valeant Offer for Obagi Medical. COLLINS, ALLISON // Mergers & Acquisitions Report;4/8/2013, Vol. 26 Issue 14, p1 

    The article offers information on the proposal of the company Merz Pharma Group to acquire the skin products company Obagi Medical Products Inc. in a deal worth 383.5 million U.S. dollars. It mentions that Valeant Pharmaceuticals International Inc. also made a 360 million U.S. dollars bid...

  • Valeant acquires Obagi Medical.  // Chain Drug Review;4/8/2013, Vol. 35 Issue 6, p9 

    The article reports on the planned acquisition of Obagi Medical Products Inc. by Valeant Pharmaceuticals International Inc. for nearly $360 million.

  • Valeant to Buy Obagi Medical.  // MMR;5/6/2013, Vol. 30 Issue 8, p28 

    The article reports that Obagi Medical Products Inc. will be acquired by Valeant Pharmaceuticals International Inc. for around 360 million dollars.

  • Valeant to Buy Medicis Pharma.  // MondayMorning;9/10/2012, Vol. 20 Issue 34, p1 

    The article provides information on the acquisition of Medicis Pharmaceutical Corp. by Valeant Pharmaceuticals International Inc. Valeant Pharmaceuticals' stocks increased by 15 percent following the announcement of the 2.6 billion U.S. dollar acquisition deal. This acquisition could help the...

  • Valeant Fires Latest Shot in Bidding War with Merz for Obagi. COLLINS, ALLISON // Mergers & Acquisitions Report;4/8/2013, Vol. 26 Issue 14, p1 

    The article informs that Valeant Pharmaceuticals International Inc. has made a bid of 418 million U.S. dollars for the acquisition of the skin product company Obagi Medical Products Inc. It mentions that Valeant tops the company Merz Pharma Group's bid of 380 million U.S. dollars for the same....

  • With Merz Out of the Running for Obagi, Valeant Gains Clear Field. NOTO, ANTHONY // Mergers & Acquisitions Report;4/15/2013, Vol. 26 Issue 15, p6 

    The article reports on the decision of Merz Pharma Group to back off from buying Obagi Medical Products Inc. after the 418 million U.S. dollar bid from Valeant Pharmaceuticals International Inc. Figures show the share price offered by Valeant to Obagi on March 20 and on April, 2013. The...

  • Merz Pharma Drops out of Bidding War for Obagi Medical.  // MondayMorning;4/15/2013, Vol. 21 Issue 14, p1 

    The article offers information on the withdrawing of its offer for U.S. cosmetic products company Obagi Medical Products Inc. by the pharmaceutical company Merz Pharma Group. It mentions that Valeant Pharmaceuticals International Inc., rival bidder of Merz Pharma has raised its offers for the...

  • Valeant Pharmaceuticals Picks Up Obagi Medical. COLLINS, ALLISON // Mergers & Acquisitions Report;3/25/2013, Vol. 26 Issue 12, p22 

    The article reports on the acquisition of skin care company Obagi Medical Products Inc. by Valeant Pharmaceuticals International Inc. for 360 million U.S. dollars. Valeant investor relations vice president Laurie Little remarked that company chief executive officer (CEO) J. Michael Pearson has...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics